<DOC>
	<DOCNO>NCT01600638</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy ZELTIQ System CoolCurve+ applicator non-invasive fat reduction flank patient population sharp body curvature .</brief_summary>
	<brief_title>Non-Invasive Reduction Fat Flanks Patients With Sharp Body Curvature</brief_title>
	<detailed_description />
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<criteria>Inclusion Criteria Male female subject &gt; 18 year age &lt; 65 year age . Subject clearly visible fat flank , investigator 's opinion , may benefit treatment . Subject weight change exceed 10 pound precede month . Subject body mass index ( BMI ) 29 . BMI define weight pound multiply 703 divide square height inch . Subject sharp flank curvature fit well CoolCurve+ applicator . Subject agree maintain his/her weight ( i.e. , within 5 pound ) make major change diet lifestyle course study . Subject read sign write informed consent form . Exclusion Criteria Subject surgical procedure ( ) area intend treatment . Subject invasive fat reduction procedure ( e.g. , liposuction , abdominoplasty , mesotherapy ) area intend treatment . Subject noninvasive fat reduction and/or body contour procedure area intend treatment within past 12 month . Subject need administer , know history subcutaneous injection area intend treatment ( e.g. , heparin , insulin ) within past month . Subject known history cryoglobulinemia , cold urticaria , paroxysmal cold hemoglobinuria . Subject known history Raynaud 's disease , know condition response cold exposure limit blood flow skin . Subject history bleed disorder take medication investigator 's opinion may increase subject 's risk bruising . Subject take take diet pill supplement within past month . Subject dermatological condition , moderate excessive skin laxity , scar location treatment site may interfere treatment evaluation ( stretch mark exclusion ) . Subject active implant device pacemaker , defibrillator , drug delivery system Subject pregnant intending become pregnant study period ( next 5 month ) . Subject lactate lactate past 6 month . Subject unable unwilling comply study requirement . Subject currently enrol clinical study unapproved investigational drug device . Any condition laboratory value would , professional opinion investigator , potentially affect subject 's response integrity data would pose unacceptable risk subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Lipolysis</keyword>
	<keyword>Cryolipolysis</keyword>
	<keyword>Fat Reduction</keyword>
</DOC>